| Kevin M Barber, MD | |
|
1592 South State Road 15-a, Deland, FL 32720 | |
| (386) 734-2931 | |
| (386) 734-2939 |
| Full Name | Kevin M Barber |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 23 Years |
| Location | 1592 South State Road 15-a, Deland, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184612269 | NPI | - | NPPES |
| AF6552 | Other | FL | MEDICARE PTAN |
| P00477812 | Other | FL | MEDICARE RR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | ME96319 (Florida) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Central Florida Eye Specialists Pl | 8820184831 | 7 |
News Archive
Silence Therapeutics plc announces the issuance of United States patent 7,732,593, titled Methods and Compositions For Controlling Efficacy of RNA Silencing, by the United States Patent and Trademark Office. The issued patent, which is based on the seminal research of Phillip D. Zamore, Ph.D., Howard Hughes Medical Institute Investigator, the Gretchen Stone Cook Chair of Biomedical Sciences, and Professor of Biochemistry & Molecular Pharmacology at University of Massachusetts Medical School, generally claims methods of enhancing the RNA silencing activity of RNA interference (RNAi) agents through certain structural modifications.
In today's payer-driven pharmaceutical marketplace, winning placement on Managed Care formularies marks only the first step for a product's increased market share. However 90 percent of executives working in Managed Care rate pull through tactics, such as health fairs and formulary update letters, as effective ways to impact demand after formulary placement.
A new study based on examination of government-collected and nationally representative data from the Democratic Republic of Congo shows that levels of rape and sexual violence against women in the country are 26 times higher than official United Nations estimates.
Drug addiction dramatically shifts a person's attention, priorities, and behaviors towards a focus almost entirely on seeking out and taking drugs. Now, an animal study funded by the National Institute on Drug Abuse, part of the National Institutes of Health, has identified some of the specific long-term adaptations in the brain's reward system that may contribute to this shift.
DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar") today announced the presentation of new data in a poster entitled, "In vivo efficacy of VAL-083 in the treatment of non-small cell lung cancer." DelMar's data was presented on Sunday, April 6, 2014 during the Novel Cytotoxic Strategies Session at the 105th Annual Meeting of the American Association for Cancer Research (AACR) in San Diego.
› Verified 9 days ago
| Entity Name | Central Florida Eye Specialists Pl |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548259898 PECOS PAC ID: 8820184831 Enrollment ID: O20071022000315 |
News Archive
Silence Therapeutics plc announces the issuance of United States patent 7,732,593, titled Methods and Compositions For Controlling Efficacy of RNA Silencing, by the United States Patent and Trademark Office. The issued patent, which is based on the seminal research of Phillip D. Zamore, Ph.D., Howard Hughes Medical Institute Investigator, the Gretchen Stone Cook Chair of Biomedical Sciences, and Professor of Biochemistry & Molecular Pharmacology at University of Massachusetts Medical School, generally claims methods of enhancing the RNA silencing activity of RNA interference (RNAi) agents through certain structural modifications.
In today's payer-driven pharmaceutical marketplace, winning placement on Managed Care formularies marks only the first step for a product's increased market share. However 90 percent of executives working in Managed Care rate pull through tactics, such as health fairs and formulary update letters, as effective ways to impact demand after formulary placement.
A new study based on examination of government-collected and nationally representative data from the Democratic Republic of Congo shows that levels of rape and sexual violence against women in the country are 26 times higher than official United Nations estimates.
Drug addiction dramatically shifts a person's attention, priorities, and behaviors towards a focus almost entirely on seeking out and taking drugs. Now, an animal study funded by the National Institute on Drug Abuse, part of the National Institutes of Health, has identified some of the specific long-term adaptations in the brain's reward system that may contribute to this shift.
DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar") today announced the presentation of new data in a poster entitled, "In vivo efficacy of VAL-083 in the treatment of non-small cell lung cancer." DelMar's data was presented on Sunday, April 6, 2014 during the Novel Cytotoxic Strategies Session at the 105th Annual Meeting of the American Association for Cancer Research (AACR) in San Diego.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kevin M Barber, MD 1592 South State Road 15-a, Deland, FL 32720 Ph: (386) 734-2931 | Kevin M Barber, MD 1592 South State Road 15-a, Deland, FL 32720 Ph: (386) 734-2931 |
News Archive
Silence Therapeutics plc announces the issuance of United States patent 7,732,593, titled Methods and Compositions For Controlling Efficacy of RNA Silencing, by the United States Patent and Trademark Office. The issued patent, which is based on the seminal research of Phillip D. Zamore, Ph.D., Howard Hughes Medical Institute Investigator, the Gretchen Stone Cook Chair of Biomedical Sciences, and Professor of Biochemistry & Molecular Pharmacology at University of Massachusetts Medical School, generally claims methods of enhancing the RNA silencing activity of RNA interference (RNAi) agents through certain structural modifications.
In today's payer-driven pharmaceutical marketplace, winning placement on Managed Care formularies marks only the first step for a product's increased market share. However 90 percent of executives working in Managed Care rate pull through tactics, such as health fairs and formulary update letters, as effective ways to impact demand after formulary placement.
A new study based on examination of government-collected and nationally representative data from the Democratic Republic of Congo shows that levels of rape and sexual violence against women in the country are 26 times higher than official United Nations estimates.
Drug addiction dramatically shifts a person's attention, priorities, and behaviors towards a focus almost entirely on seeking out and taking drugs. Now, an animal study funded by the National Institute on Drug Abuse, part of the National Institutes of Health, has identified some of the specific long-term adaptations in the brain's reward system that may contribute to this shift.
DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar") today announced the presentation of new data in a poster entitled, "In vivo efficacy of VAL-083 in the treatment of non-small cell lung cancer." DelMar's data was presented on Sunday, April 6, 2014 during the Novel Cytotoxic Strategies Session at the 105th Annual Meeting of the American Association for Cancer Research (AACR) in San Diego.
› Verified 9 days ago
Thomas M. Kropp, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 305 E New York Ave, Deland, FL 32724 Phone: 386-734-2931 Fax: 386-734-2939 | |
Robert Cordero, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 1592 South State Road 15-a, Deland, FL 32720 Phone: 386-734-2931 Fax: 386-734-2939 | |
Dr. Kourosh Nazari, M.D. Ophthalmology Medicare: May Accept Medicare Assignments Practice Location: 801 N Stone St, Deland, FL 32720 Phone: 386-734-4431 Fax: 386-738-1045 | |
Ryan Scruggs, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1592 South State Road 15-a, Deland, FL 32720 Phone: 386-734-2931 |